One-carbon Therapeutics
  • HOME
  • ABOUT US
    • ABOUT US
    • BOARD OF DIRECTORS
    • MANAGEMENT
    • SCIENTIFIC ADVISORY BOARD
  • OUR SCIENCE
    • OUR SCIENCE
    • CANCER METABOLISM
    • ONE-CARBON METABOLISM
    • DNA DAMAGE RESPONSE (DDR)
    • MTHFD2
  • NEWS
  • CONTACT US
Select Page

AACR21 virtual meeting

by admin | May 17, 2021 | News | 0 comments

Prof Thomas Helleday presents MTHFD2 and other emerging targets such as PKMYT1, MTH1 and Pol Theta at the AACR21 virtual meeting

  • Facebook
  • Twitter
  • Instagram
  • RSS
© one-carbon therapeutics 2021